This is an open-label, multi-center, dose escalation study in adult subjects with advanced colorectal, gastric, hepatic or pancreatic cancer. The study will evaluate the safety, tolerability, pharmaco
AimNiclosamide is an established anthelmintic substance and a promising candidate for treating cancer, viral infections, and other diseases. However, its solubility in aqueous media is low, and the sy
This data is part of the manuscript "In vitro and in vivo phasor analysis of stoichiometry and pharmacokinetics using near-infrared dyes" by Sez-Jade Chen, Nattawut Sinsuebphon, Alena Rudkouskaya, Mar
Intervention1: Capecitabine 500mg (Relicitabine): Patients will be administered drug (Test or the Comparator depending on the Randomization sequence) on Day 1, Day 2, Day 3 of the study (in single tre
